Who
Michael Charles Ferguson Hannay
Chief Prod & Supply Chain Off
Company insider
Files Form 4 as: Chief Prod & Supply Chain Off, Bicycle Therapeutics.
In numbers
- Trades disclosed
- 34
- Buys
- 0
- Sells
- 19
- Bought
- $0
- Sold
- $171K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 19 Mar 2024
- Last trade
- 5 Oct 2026
- Last filed
- 6 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 6 Oct 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $864242 at $3.57 | filing |
| 2 Oct 2026filed 6 Oct 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $5,4551,572 at $3.47 | filing |
| 15 Jul 2026filed 17 Jul 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,099255 at $4.31 | filing |
| 6 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,099255 at $4.31 | filing |
| 2 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $6,4311,506 at $4.27 | filing |
| 2 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $6,4311,506 at $4.27 | filing |
| 6 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,268251 at $5.05 | filing |
| 6 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,268251 at $5.05 | filing |
| 2 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,4681,521 at $4.91 | filing |
| 2 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,4681,521 at $4.91 | filing |
| 5 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $15K2,367 at $6.45 | filing |
| 5 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $15K2,367 at $6.45 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $19K2,827 at $6.80 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $19K2,827 at $6.80 | filing |
News
No headline names them, or the companies they trade most, lately.